MGAT2 Inhibitors (VENENUM Biodesign)

N/A

Report date: 2025/01/26 16:25:39
NME

Base Information

Drug NameMGAT2 Inhibitors (VENENUM Biodesign)
Drug Alias NameMGAT2 inhibitors (VENENUM Biodesign)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action2-acylglycerol O-acyltransferase 2 inhibitors
Targets2-acylglycerol O-acyltransferase 2
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVenenum Biodesign LLC
China Registration ClassN/A

Develop Information

Active CompaniesVenenum Biodesign LLC
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A